Copper-based theranostic nanocatalysts for synergetic photothermal-chemodynamic therapy

Chemodynamic therapy (CDT) has aroused extensive attention as a potent therapeutic modality. However, its practical application is severely restricted by the strong acidity requirement for Fenton reaction and upregulated antioxidant defense within metastatic breast cancer. Herein, a copper-based sin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta biomaterialia 2022-07, Vol.147, p.258-269
Hauptverfasser: Zuo, Wenbao, Fan, Zhongxiong, Chen, Luping, Liu, Jinxue, Wan, Zheng, Xiao, Zhimei, Chen, Weibin, Wu, Liang, Chen, Dengyue, Zhu, Xuan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 269
container_issue
container_start_page 258
container_title Acta biomaterialia
container_volume 147
creator Zuo, Wenbao
Fan, Zhongxiong
Chen, Luping
Liu, Jinxue
Wan, Zheng
Xiao, Zhimei
Chen, Weibin
Wu, Liang
Chen, Dengyue
Zhu, Xuan
description Chemodynamic therapy (CDT) has aroused extensive attention as a potent therapeutic modality. However, its practical application is severely restricted by the strong acidity requirement for Fenton reaction and upregulated antioxidant defense within metastatic breast cancer. Herein, a copper-based single-site nanocatalyst functionalized with carbonic anhydrase inhibitor (CAI) was constructed for magnetic resonance/photoacoustic imaging (MRI/PA)-guided synergetic photothermal therapy (PTT) and CDT. Once reaching tumor sites, the nanocatalyst can be recognized by tumor cell membranes-overexpressed carbonic anhydrase IX (CA IX). Subsequently, the single-site CuII can be reduced to CuI by the tumor-overexpressed glutathione (GSH), which simultaneously impaired the tumor antioxidant defense system and triggered CAI release for inducing intracellular H+ accumulation. Further, the decreased intracellular pH can accelerate the nanocatalyst biodegradation to release more CuII and CAI to participate in next-cycle GSH-depletion and cytoplasm acidification, respectively, thereby continuously supplying CuI and H+ for self-cyclically amplified CDT. Upon laser irradiation, the nanocatalyst can generate local heat, which not only permits PTT but also enhances the nanocatalyst-mediated CDT. Moreover, the suppression of CA IX can hinder the tumor extracellular matrix degradation to prevent tumor metastasis. Overall, this work highlighted the great application prospect in enhancing CDT via tumor acidic/redox microenvironment remodeling, and provides an insightful paradigm for inhibiting breast cancer metastasis. The practical application of chemodynamic therapy (CDT) is severely restricted by the strong acidity requirement for Fenton reaction and upregulated antioxidant defense within cancer. Herein, we developed a carbonic anhydrase inhibitor (CAI)-functionalized Cu-based nanocatalyst. Once reaching tumor sites, the CuII can be reduced to CuI by the tumor-overexpressed glutathione (GSH), which simultaneously impaired the tumor antioxidant system and triggered CAI release for inducing intracellular H+ accumulation. Further, the decreased intracellular pH can accelerate the nanocatalyst biodegradation to release more CuII and CAI to participate in next-cycle GSH-depletion and cytoplasm acidification, respectively, thus continuously supplying CuI and H+ for self-cyclically amplified CDT. Upon laser irradiation, the nanocatalyst not only permits PTT but also enhances the CDT. [Di
doi_str_mv 10.1016/j.actbio.2022.05.030
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2668909763</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1742706122003063</els_id><sourcerecordid>2668909763</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-b5655a21a8866664813c53797a00e21177d84c7a25912ca467c1ed447d142e263</originalsourceid><addsrcrecordid>eNp9kEtPwzAMgCMEYmPwDxDakUtLkubVCxKaeEmTuIA4RlnqsU5tU5IMqf-elA2O-GJL_mzLH0KXBOcEE3GzzY2Nq9rlFFOaY57jAh-hKVFSZZILdZxqyWgmsSATdBbCFuNCEapO0aTgAvOSsyl6X7i-B5-tTIBqHjfgTedCrO28S4U10TRDiGG-dn4ehg78B4zNfuOiG-nWNJndQOuqoTNt6vys6IdzdLI2TYCLQ56ht4f718VTtnx5fF7cLTNbCBqzFRecG0qMUiIFU6SwvJClNBgDJUTKSjErDeUlodYwIS2BijFZEUaBimKGrvd7e-8-dxCibutgoWlMB24XNBVClbiUokgo26PWuxA8rHXv69b4QROsR6V6q_dK9ahUY66T0jR2dbiwW7VQ_Q39OkzA7R6A9OdXDV4HW0Nnoao92KgrV_9_4RtaZong</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2668909763</pqid></control><display><type>article</type><title>Copper-based theranostic nanocatalysts for synergetic photothermal-chemodynamic therapy</title><source>ScienceDirect Freedom Collection (Elsevier)</source><creator>Zuo, Wenbao ; Fan, Zhongxiong ; Chen, Luping ; Liu, Jinxue ; Wan, Zheng ; Xiao, Zhimei ; Chen, Weibin ; Wu, Liang ; Chen, Dengyue ; Zhu, Xuan</creator><creatorcontrib>Zuo, Wenbao ; Fan, Zhongxiong ; Chen, Luping ; Liu, Jinxue ; Wan, Zheng ; Xiao, Zhimei ; Chen, Weibin ; Wu, Liang ; Chen, Dengyue ; Zhu, Xuan</creatorcontrib><description>Chemodynamic therapy (CDT) has aroused extensive attention as a potent therapeutic modality. However, its practical application is severely restricted by the strong acidity requirement for Fenton reaction and upregulated antioxidant defense within metastatic breast cancer. Herein, a copper-based single-site nanocatalyst functionalized with carbonic anhydrase inhibitor (CAI) was constructed for magnetic resonance/photoacoustic imaging (MRI/PA)-guided synergetic photothermal therapy (PTT) and CDT. Once reaching tumor sites, the nanocatalyst can be recognized by tumor cell membranes-overexpressed carbonic anhydrase IX (CA IX). Subsequently, the single-site CuII can be reduced to CuI by the tumor-overexpressed glutathione (GSH), which simultaneously impaired the tumor antioxidant defense system and triggered CAI release for inducing intracellular H+ accumulation. Further, the decreased intracellular pH can accelerate the nanocatalyst biodegradation to release more CuII and CAI to participate in next-cycle GSH-depletion and cytoplasm acidification, respectively, thereby continuously supplying CuI and H+ for self-cyclically amplified CDT. Upon laser irradiation, the nanocatalyst can generate local heat, which not only permits PTT but also enhances the nanocatalyst-mediated CDT. Moreover, the suppression of CA IX can hinder the tumor extracellular matrix degradation to prevent tumor metastasis. Overall, this work highlighted the great application prospect in enhancing CDT via tumor acidic/redox microenvironment remodeling, and provides an insightful paradigm for inhibiting breast cancer metastasis. The practical application of chemodynamic therapy (CDT) is severely restricted by the strong acidity requirement for Fenton reaction and upregulated antioxidant defense within cancer. Herein, we developed a carbonic anhydrase inhibitor (CAI)-functionalized Cu-based nanocatalyst. Once reaching tumor sites, the CuII can be reduced to CuI by the tumor-overexpressed glutathione (GSH), which simultaneously impaired the tumor antioxidant system and triggered CAI release for inducing intracellular H+ accumulation. Further, the decreased intracellular pH can accelerate the nanocatalyst biodegradation to release more CuII and CAI to participate in next-cycle GSH-depletion and cytoplasm acidification, respectively, thus continuously supplying CuI and H+ for self-cyclically amplified CDT. Upon laser irradiation, the nanocatalyst not only permits PTT but also enhances the CDT. [Display omitted]</description><identifier>ISSN: 1742-7061</identifier><identifier>EISSN: 1878-7568</identifier><identifier>DOI: 10.1016/j.actbio.2022.05.030</identifier><identifier>PMID: 35605954</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Chemodynamic therapy ; Metastatic breast cancer ; Photothermal therapy ; Single-site nanocatalyst ; Tumor microenvironment remodeling</subject><ispartof>Acta biomaterialia, 2022-07, Vol.147, p.258-269</ispartof><rights>2022</rights><rights>Copyright © 2022. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-b5655a21a8866664813c53797a00e21177d84c7a25912ca467c1ed447d142e263</citedby><cites>FETCH-LOGICAL-c362t-b5655a21a8866664813c53797a00e21177d84c7a25912ca467c1ed447d142e263</cites><orcidid>0000-0003-1581-9767</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.actbio.2022.05.030$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35605954$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zuo, Wenbao</creatorcontrib><creatorcontrib>Fan, Zhongxiong</creatorcontrib><creatorcontrib>Chen, Luping</creatorcontrib><creatorcontrib>Liu, Jinxue</creatorcontrib><creatorcontrib>Wan, Zheng</creatorcontrib><creatorcontrib>Xiao, Zhimei</creatorcontrib><creatorcontrib>Chen, Weibin</creatorcontrib><creatorcontrib>Wu, Liang</creatorcontrib><creatorcontrib>Chen, Dengyue</creatorcontrib><creatorcontrib>Zhu, Xuan</creatorcontrib><title>Copper-based theranostic nanocatalysts for synergetic photothermal-chemodynamic therapy</title><title>Acta biomaterialia</title><addtitle>Acta Biomater</addtitle><description>Chemodynamic therapy (CDT) has aroused extensive attention as a potent therapeutic modality. However, its practical application is severely restricted by the strong acidity requirement for Fenton reaction and upregulated antioxidant defense within metastatic breast cancer. Herein, a copper-based single-site nanocatalyst functionalized with carbonic anhydrase inhibitor (CAI) was constructed for magnetic resonance/photoacoustic imaging (MRI/PA)-guided synergetic photothermal therapy (PTT) and CDT. Once reaching tumor sites, the nanocatalyst can be recognized by tumor cell membranes-overexpressed carbonic anhydrase IX (CA IX). Subsequently, the single-site CuII can be reduced to CuI by the tumor-overexpressed glutathione (GSH), which simultaneously impaired the tumor antioxidant defense system and triggered CAI release for inducing intracellular H+ accumulation. Further, the decreased intracellular pH can accelerate the nanocatalyst biodegradation to release more CuII and CAI to participate in next-cycle GSH-depletion and cytoplasm acidification, respectively, thereby continuously supplying CuI and H+ for self-cyclically amplified CDT. Upon laser irradiation, the nanocatalyst can generate local heat, which not only permits PTT but also enhances the nanocatalyst-mediated CDT. Moreover, the suppression of CA IX can hinder the tumor extracellular matrix degradation to prevent tumor metastasis. Overall, this work highlighted the great application prospect in enhancing CDT via tumor acidic/redox microenvironment remodeling, and provides an insightful paradigm for inhibiting breast cancer metastasis. The practical application of chemodynamic therapy (CDT) is severely restricted by the strong acidity requirement for Fenton reaction and upregulated antioxidant defense within cancer. Herein, we developed a carbonic anhydrase inhibitor (CAI)-functionalized Cu-based nanocatalyst. Once reaching tumor sites, the CuII can be reduced to CuI by the tumor-overexpressed glutathione (GSH), which simultaneously impaired the tumor antioxidant system and triggered CAI release for inducing intracellular H+ accumulation. Further, the decreased intracellular pH can accelerate the nanocatalyst biodegradation to release more CuII and CAI to participate in next-cycle GSH-depletion and cytoplasm acidification, respectively, thus continuously supplying CuI and H+ for self-cyclically amplified CDT. Upon laser irradiation, the nanocatalyst not only permits PTT but also enhances the CDT. [Display omitted]</description><subject>Chemodynamic therapy</subject><subject>Metastatic breast cancer</subject><subject>Photothermal therapy</subject><subject>Single-site nanocatalyst</subject><subject>Tumor microenvironment remodeling</subject><issn>1742-7061</issn><issn>1878-7568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPwzAMgCMEYmPwDxDakUtLkubVCxKaeEmTuIA4RlnqsU5tU5IMqf-elA2O-GJL_mzLH0KXBOcEE3GzzY2Nq9rlFFOaY57jAh-hKVFSZZILdZxqyWgmsSATdBbCFuNCEapO0aTgAvOSsyl6X7i-B5-tTIBqHjfgTedCrO28S4U10TRDiGG-dn4ehg78B4zNfuOiG-nWNJndQOuqoTNt6vys6IdzdLI2TYCLQ56ht4f718VTtnx5fF7cLTNbCBqzFRecG0qMUiIFU6SwvJClNBgDJUTKSjErDeUlodYwIS2BijFZEUaBimKGrvd7e-8-dxCibutgoWlMB24XNBVClbiUokgo26PWuxA8rHXv69b4QROsR6V6q_dK9ahUY66T0jR2dbiwW7VQ_Q39OkzA7R6A9OdXDV4HW0Nnoao92KgrV_9_4RtaZong</recordid><startdate>20220715</startdate><enddate>20220715</enddate><creator>Zuo, Wenbao</creator><creator>Fan, Zhongxiong</creator><creator>Chen, Luping</creator><creator>Liu, Jinxue</creator><creator>Wan, Zheng</creator><creator>Xiao, Zhimei</creator><creator>Chen, Weibin</creator><creator>Wu, Liang</creator><creator>Chen, Dengyue</creator><creator>Zhu, Xuan</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1581-9767</orcidid></search><sort><creationdate>20220715</creationdate><title>Copper-based theranostic nanocatalysts for synergetic photothermal-chemodynamic therapy</title><author>Zuo, Wenbao ; Fan, Zhongxiong ; Chen, Luping ; Liu, Jinxue ; Wan, Zheng ; Xiao, Zhimei ; Chen, Weibin ; Wu, Liang ; Chen, Dengyue ; Zhu, Xuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-b5655a21a8866664813c53797a00e21177d84c7a25912ca467c1ed447d142e263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Chemodynamic therapy</topic><topic>Metastatic breast cancer</topic><topic>Photothermal therapy</topic><topic>Single-site nanocatalyst</topic><topic>Tumor microenvironment remodeling</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zuo, Wenbao</creatorcontrib><creatorcontrib>Fan, Zhongxiong</creatorcontrib><creatorcontrib>Chen, Luping</creatorcontrib><creatorcontrib>Liu, Jinxue</creatorcontrib><creatorcontrib>Wan, Zheng</creatorcontrib><creatorcontrib>Xiao, Zhimei</creatorcontrib><creatorcontrib>Chen, Weibin</creatorcontrib><creatorcontrib>Wu, Liang</creatorcontrib><creatorcontrib>Chen, Dengyue</creatorcontrib><creatorcontrib>Zhu, Xuan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta biomaterialia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zuo, Wenbao</au><au>Fan, Zhongxiong</au><au>Chen, Luping</au><au>Liu, Jinxue</au><au>Wan, Zheng</au><au>Xiao, Zhimei</au><au>Chen, Weibin</au><au>Wu, Liang</au><au>Chen, Dengyue</au><au>Zhu, Xuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Copper-based theranostic nanocatalysts for synergetic photothermal-chemodynamic therapy</atitle><jtitle>Acta biomaterialia</jtitle><addtitle>Acta Biomater</addtitle><date>2022-07-15</date><risdate>2022</risdate><volume>147</volume><spage>258</spage><epage>269</epage><pages>258-269</pages><issn>1742-7061</issn><eissn>1878-7568</eissn><abstract>Chemodynamic therapy (CDT) has aroused extensive attention as a potent therapeutic modality. However, its practical application is severely restricted by the strong acidity requirement for Fenton reaction and upregulated antioxidant defense within metastatic breast cancer. Herein, a copper-based single-site nanocatalyst functionalized with carbonic anhydrase inhibitor (CAI) was constructed for magnetic resonance/photoacoustic imaging (MRI/PA)-guided synergetic photothermal therapy (PTT) and CDT. Once reaching tumor sites, the nanocatalyst can be recognized by tumor cell membranes-overexpressed carbonic anhydrase IX (CA IX). Subsequently, the single-site CuII can be reduced to CuI by the tumor-overexpressed glutathione (GSH), which simultaneously impaired the tumor antioxidant defense system and triggered CAI release for inducing intracellular H+ accumulation. Further, the decreased intracellular pH can accelerate the nanocatalyst biodegradation to release more CuII and CAI to participate in next-cycle GSH-depletion and cytoplasm acidification, respectively, thereby continuously supplying CuI and H+ for self-cyclically amplified CDT. Upon laser irradiation, the nanocatalyst can generate local heat, which not only permits PTT but also enhances the nanocatalyst-mediated CDT. Moreover, the suppression of CA IX can hinder the tumor extracellular matrix degradation to prevent tumor metastasis. Overall, this work highlighted the great application prospect in enhancing CDT via tumor acidic/redox microenvironment remodeling, and provides an insightful paradigm for inhibiting breast cancer metastasis. The practical application of chemodynamic therapy (CDT) is severely restricted by the strong acidity requirement for Fenton reaction and upregulated antioxidant defense within cancer. Herein, we developed a carbonic anhydrase inhibitor (CAI)-functionalized Cu-based nanocatalyst. Once reaching tumor sites, the CuII can be reduced to CuI by the tumor-overexpressed glutathione (GSH), which simultaneously impaired the tumor antioxidant system and triggered CAI release for inducing intracellular H+ accumulation. Further, the decreased intracellular pH can accelerate the nanocatalyst biodegradation to release more CuII and CAI to participate in next-cycle GSH-depletion and cytoplasm acidification, respectively, thus continuously supplying CuI and H+ for self-cyclically amplified CDT. Upon laser irradiation, the nanocatalyst not only permits PTT but also enhances the CDT. [Display omitted]</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>35605954</pmid><doi>10.1016/j.actbio.2022.05.030</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-1581-9767</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1742-7061
ispartof Acta biomaterialia, 2022-07, Vol.147, p.258-269
issn 1742-7061
1878-7568
language eng
recordid cdi_proquest_miscellaneous_2668909763
source ScienceDirect Freedom Collection (Elsevier)
subjects Chemodynamic therapy
Metastatic breast cancer
Photothermal therapy
Single-site nanocatalyst
Tumor microenvironment remodeling
title Copper-based theranostic nanocatalysts for synergetic photothermal-chemodynamic therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T05%3A29%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Copper-based%20theranostic%20nanocatalysts%20for%20synergetic%20photothermal-chemodynamic%20therapy&rft.jtitle=Acta%20biomaterialia&rft.au=Zuo,%20Wenbao&rft.date=2022-07-15&rft.volume=147&rft.spage=258&rft.epage=269&rft.pages=258-269&rft.issn=1742-7061&rft.eissn=1878-7568&rft_id=info:doi/10.1016/j.actbio.2022.05.030&rft_dat=%3Cproquest_cross%3E2668909763%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2668909763&rft_id=info:pmid/35605954&rft_els_id=S1742706122003063&rfr_iscdi=true